[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100533439":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":33,"responsibleParty":50,"collaborators":54,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":20,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":20,"enrollmentInfo":66,"targetDuration":20,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":20,"overallStatus":36,"whyStopped":20,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Albert Einstein Healthcare Network","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Ekso mediated gait training","EXPERIMENTAL","Ekso mediated gait training will take place twice per week for 8 weeks . An Ekso Robotic Eksoskeleton will be used during each treatment session; this device can physically assist leg movements along a customized path or resist or amplify movements the participant makes. Each session will be 60 minutes and will be 3 rounds of 15 minutes of Ekso mediated gait training.\n\nFour (4) study related Assessment sessions will be conducted and include a series of physical tests and a written questionnaire. This will be done at the Evaluation\u002F 1st visit, then the re-evaluation at visit 9, at discharge or visit 17, and finally at a 3-month follow-up.",[13],"Device: Eksobionics Eksoskeleton NR",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Eksobionics Eksoskeleton NR","During treatment sessions, the therapist will guide the participant's progress using a specific plan. The therapist will set a trajectory for each leg, determining the appropriate step height and length, and program it into the Ekso device. The Ekso will then assist the participant by following this trajectory, with varying levels of assistance for each step. As the participant improves, the therapist will gradually reduce the assistance provided until the participant reaches a point where they no longer require assistance or reach a plateau. In the final phase, the trajectory will be removed, and the participant will walk using their own movements. The therapist may add resistance or assistance based on the participant's needs, but it will be in line with their self-generated movements rather than a predetermined path.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Jacqueline Brown, DPT","PRINCIPAL_INVESTIGATOR",[26,30],{"name":23,"role":27,"phone":28,"phoneExt":20,"email":29},"CONTACT","215-663-6575","Jxb892@jefferson.edu",{"name":31,"role":27,"phone":28,"phoneExt":20,"email":32},"Kris Ferrara, DPT","Kristopher.Ferrara@jefferson.edu",[34],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Jefferson Moss-Magee Rehabilitation - Elkins Park","RECRUITING","Elkins Park","Pennsylvania","19027","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-75.12684,40.07706,{"lat":46,"lon":45},[49],{"name":23,"role":24,"phone":20,"phoneExt":20,"email":20},{"type":24,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":53,"oldNameTitle":20,"oldOrganization":20},"Jacqueline Brown","Senior Physical Therapist, Jefferson Moss Magee Rehabilitation","Thomas Jefferson University",[55],{"name":56,"class":6},"Moss Rehabilitation Research Institute","100533439","unlocking-movement-potential-enhancing-parkinsons-disease-treatment-with-robotic-eksoskeleton-100533439",false,"NCT06225830","Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton","Utilization of Robotic EksoSkeleton to Achieve High Dosing, Intensity, and Complexity of Gait in Treatment of People With Parkinson's Disease","Inclusion Criteria:\n\n1. Physician diagnosed idiopathic Parkinson's disease\n2. All Hoehn and Yahr (H\\&Y) stages will be eligible for inclusion in the study\n3. Able to consent to participation in the research study\n4. Pt agreeable to participate in 45-60 minutes of high intensity (RPE 14-17 for 30 minutes) gait training\u002F physical therapy.\n5. Sufficient upper extremity strength to use a front wheeled walker\n6. Pt to have self- reported walking\u002Fbalance deficits\n7. Age: Over age 18\n8. Must be able to tolerate at least 15 min upright\n9. Weigh 220 pounds (100kg) or less\n10. Approximately between 5'0\" and 6'4\" tall\n11. Have near normal range of motion in hips, knees, and ankles \"Can you stand up and straighten your knees even for just a second?\" or \"Can you lay flat and straighten your knees so there is no bend in the knee?\"\n\nExclusion Criteria:\n\n1. Currently involved in another intervention study or physical therapy course of care\n2. Concurrent neurological disease\n3. Leg length discrepancy, self-reported.\n4. Spinal instability\n5. Unresolved deep vein thrombosis\n6. Severe muscular or skeletal pain\n7. Open skin ulcerations on buttocks or other body surfaces in contact with exoskeleton or harness\n8. Pregnancy\n9. Cognitive impairments - unable to follow 2 steps commands and communicate for pain or to stop session\n10. Participant requires the assistance of more than one therapist to transfer safely.\n11. Uncontrolled or severe orthostatic hypotension that limits standing tolerance; defined as sustained, symptomatic drops in systolic and diastolic blood pressure when moving from sitting to standing\n12. Active heterotrophic ossification (HO), hip dysplasia or hip\u002Fknee axis abnormalities\n13. Colostomy\n14. History of long bone fractures secondary to osteoporosis\n15. Unable to sustain current medication regimen. Participant reports change in Parkinson's Medication in the past week.\n16. Any reason the therapist may deem as harmful to the participant to enroll or continue in the study","ALL","18 Years",{"count":67,"type":68},24,"ESTIMATED","INTERVENTIONAL",[71],"NA","The goal of this study is to see how well therapy with the Eksobionic Exoskeleton (Esko) works for people with Parkinson's disease (PWPD). Esko is a robotic device that provides high repetition and intensity training. The investigators will examine its impact on walking, balance, and quality of life before, during and after an eight-week intervention program. The results will lay the groundwork for future trials, potentially leading to long-term improvements in mobility and quality of life for PWPD.",[74],"Parkinson Disease","2025-07-06",{"date":77,"type":78},"2025-07-10","ACTUAL",{"date":80,"type":78},"2024-06-04",{"date":82,"type":68},"2026-06",{"name":5,"class":6},1]